CARGO Therapeutics, Inc. (CRGX)
NASDAQ: CRGX · Real-Time Price · USD
15.73
-0.09 (-0.57%)
Nov 21, 2024, 4:00 PM EST - Market closed
CARGO Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -154.14 | -98.15 | -40.95 | -5.85 |
| Depreciation & Amortization | 6.81 | 3.69 | 1.44 | 0.15 |
| Asset Writedown & Restructuring Costs | 0.55 | 1.51 | 1.01 | - |
| Stock-Based Compensation | 14.76 | 3.33 | 0.3 | 0.51 |
| Other Operating Activities | 0.44 | 6.25 | 6.16 | - |
| Change in Accounts Payable | -1.49 | 0.76 | 2.82 | 0.33 |
| Change in Other Net Operating Assets | 3.31 | 1.45 | 0.15 | -0.08 |
| Operating Cash Flow | -133.84 | -81.16 | -29.07 | -4.94 |
| Capital Expenditures | -6.43 | -8.28 | -2.72 | -0.44 |
| Sale (Purchase) of Intangibles | -1.31 | -0.72 | -0.56 | - |
| Investing Cash Flow | -336.32 | -8.99 | -3.28 | -0.44 |
| Short-Term Debt Issued | - | 3.5 | 28.45 | - |
| Total Debt Issued | - | 3.5 | 28.45 | - |
| Net Debt Issued (Repaid) | - | 3.5 | 28.45 | - |
| Issuance of Common Stock | 400.41 | 296.64 | 0.23 | - |
| Other Financing Activities | -4.84 | -5.47 | - | - |
| Financing Cash Flow | 481.56 | 494.58 | 34.19 | 5.41 |
| Net Cash Flow | 11.4 | 404.43 | 1.83 | 0.03 |
| Free Cash Flow | -140.27 | -89.44 | -31.8 | -5.38 |
| Free Cash Flow Per Share | -3.65 | -15.06 | -81.06 | -35.32 |
| Levered Free Cash Flow | -112.93 | -68.1 | -7.91 | - |
| Unlevered Free Cash Flow | -112.93 | -67.1 | -4.82 | - |
| Change in Net Working Capital | 19.14 | 4.68 | -18.45 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.